PeterLabs Holdings Berhad

RM 0.24As of Sun 8 Nov 2026, 12:00 UTC
KLSE:PLABSHealthcare
Country Malaysia
PE (Fwd) •••
TSR 10Y CAGR 1.60%
Div yield —
ROE (2.78%)
Pharmaceutical Preparations
Beta (5Y) 0.33
PE TTM —
TSR TTM 2.13%
Mkt cap RM 66.05M
ROIC (3.25%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
RM 0.259
7.87%
94.78%
Hold 2|8|4|2|4
2Q26
3Q26
4Q26
1Q27
Earnings per shareRM
—
—
—
—
5.35%
6.04%
18.45%
25.91%
RevenueRM M
3.925
4.000
3.941
3.834
4.16%
4.41%
3.36%
0.29%
Peers (US$16.28M)
Cap (US$)
PE
37.37M
12.38x
30.25M
14.38x
Capital
TTM
5Y
10Y
Leveragex
0.413
0.960
0.948
EBIT/Intx
8.579
0.590
0.785
Own earn%
622.65
0.35
0.67
Sh yield%
30.55
38.07
36.75
Owners
Insiders/Inst%
1.54
42.07
Short interest%
4.33
SBC / revenue%
4.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
0–2
$1 testx
—
Incr. ROIC%
2